Enanta Pharmaceuticals Inc. buy Rodman & Renshaw
Start price
26.03.26
/
50%
€10.60
Target price
26.03.27
€17.30
Performance (%)
-5.66%
Price
04.06.26
€10.00
Summary
This prediction is currently active. With a performance of -5.66%, the BUY prediction by Rodman___Renshaw is trending in the wrong direction. This prediction currently runs until 26.03.27. The prediction end date can be changed by Rodman___Renshaw at any time. Rodman___Renshaw has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Enanta Pharmaceuticals Inc. | -16.071% | -16.071% |
| iShares Core DAX® | -0,68 % | 4,05 % |
| iShares Nasdaq 100 | 0,99 % | 10,87 % |
| iShares Nikkei 225® | 3,28 % | 13,47 % |
| iShares S&P 500 | 0,62 % | 6,20 % |
Comments by Rodman___Renshaw for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals (ENTA) is now covered by Rodman & Renshaw. They set a "buy" rating and a $20.00 price target on the stock.
Ratings data for ENTA provided by MarketBeat